Contribute to medical innovation by voluntarily enrolling on a Clinical Trial today
This is a basic breakdown of what to expect when thinking about participating in a Clinical Trial. Remember, it is always best to consult one of our Investigators (Medical Doctors) in order to make an informed decision.
Informed Consent: Before joining a trial, we provide detailed information about the study, its purpose, potential risks, and benefits. You’ll have the opportunity to ask questions, ensuring you fully understand what participation entails.
Screening and Eligibility: We’ll conduct a thorough screening process to determine if you meet the specific criteria for the trial. This ensures the trial’s results are meaningful and relevant to individuals with similar characteristics.
Baseline Assessments: Once eligible, we’ll perform baseline assessments, including medical history, physical exams, and necessary tests. This helps establish a starting point for comparison throughout the study.
Treatment Phase: If you’re randomized into the treatment group, you’ll receive the investigational treatment. If you’re in the control group, you may receive the standard treatment or a placebo, depending on the study design.
Regular Monitoring: Throughout the trial, we’ll closely monitor your health, conduct regular check-ups, and perform necessary tests. Your well-being is our priority, and any changes or concerns will be addressed promptly.
Follow-Up Period: After completing the treatment phase, there is usually a follow-up period where we continue to monitor your health to assess the long-term effects of the treatment.
Trial Completion: Upon completing the trial, you’ve not only contributed to advancing medical knowledge but may have also gained access to new and effective treatments before they are widely available.
Clinical trials provide individuals with certain medical conditions an alternative or additional treatment option. It’s a chance to receive expert medical care, regular monitoring, and the satisfaction of knowing that your involvement contributes to the broader scientific understanding of health and wellness. Overall, joining a clinical trial is not only a personal health decision but a meaningful contribution to the progress of medical science.
Please be aware that participation in clinical trials is entirely voluntary, and the study team, including the investigator (Medical Doctor), will thoroughly inform you about potential risks and benefits. Your well-being is our top priority, and we encourage you to make an informed decision about your participation.
These studies present a unique opportunity for individuals to contribute to cutting-edge medical research. If you are interested in participating or learning more about this active trial, kindly reach out to our dedicated study team for comprehensive information and enrollment details.
Clinical Trials.gov ID: NCT06062238
Study ID Number: Gates MRI-TBV02-301
Overview:
The study is a randomized, double-blind, placebo-controlled, multicenter, clinical trial to assess the prophylactic efficacy, safety, and immunogenicity of the investigational M72/AS01E-4 Mtb vaccine when administered intramuscularly (IM) on a 0,1-month schedule to adolescents and adults. This trial will be conducted in 3 cohorts: Interferon gamma release assay (IGRA)-positive Cohort, IGRA-Negative Cohort and Human Immunodeficiency virus (HIV) Cohort.
Find out more information on clinicaltrials.gov: https://clinicaltrials.gov/study/NCT06062238
Approved Resources:
Click to Download Study Brochure (currently unavailable)
Contact Information:
Reach out with questions or concerns.
Trident Clinical Offices : (+27) 53 050 1257 | 12 Angel Street, New Park, Kimberley, 8301 | info@tridentclinical.co.za
ClinicalTrials.gov ID : NCT05531149
Study Number: TRICOVID
Overview:
The main objectives of the trial are to assess the efficacy and safety of trimodulin as adjunctive treatment to standard of care (SoC) compared to placebo plus SoC in adult hospitalized subjects with non-severe community-acquired pneumonia (CAP) or moderate / severe Coronavirus Disease 2019 (COVID-19) pneumonia.
Other objectives are to determine pharmacokinetic (PK) and pharmacodynamic (PD) properties of trimodulin.
Find out more information on clinicaltrials.gov: https://clinicaltrials.gov/study/NCT05531149
Approved Resources:
Click to Download Study Brochure (currently unavailable)
Contact Information:
Reach out with questions or concerns.
Trident Clinical Offices : (+27) 53 050 1257 | 12 Angel Street, New Park, Kimberley, 8301 | info@tridentclinical.co.za
ClinicalTrials.gov ID: NCT05569005
Study ID Number: P1-COPD-04-INT
Overview:
The purpose of this study is to demonstrate the slowing of the disease progression including the improvement of Chronic Obstructive Pulmonary Disease (COPD) symptoms in smoking subjects with mild to moderate COPD and a history of chronic bronchitis symptoms (sputum and cough) who switch to the Tobacco Heating System (THS) as compared to those who continue to smoke cigarettes.
Find out more information on clinicaltrials.gov: https://clinicaltrials.gov/study/NCT05569005
Approved Resources:
Click to Download Study Brochure (currently unavailable)
Contact Information:
Reach out with questions or concerns.
Trident Clinical Offices : (+27) 53 050 1257 | 12 Angel Street, New Park, Kimberley, 8301 | info@tridentclinical.co.za
Closed clinical trials that have contributed to medical knowledge and advancements. While enrollment for these studies has concluded, their outcomes continue to shape the future of healthcare. For more details on the findings and impact of our past studies, feel free to connect with our research team.
ClinicalTrials.gov ID: NCT03338218
Study ID Number: HC-G-H-1505
Overview:
The aim of the study is to investigate the safety of a 6% hydroxyethyl starch (HES) solution (Volulyte 6%) versus an electrolyte solution (Ionolyte) in trauma patients.
Find out more information on clinicaltrials.gov: https://clinicaltrials.gov/study/NCT03338218
Total Participants enrolled by Trident Clinical: 164
ClinicalTrials.gov ID: NCT05190146
Study ID Number: Gates MRI TBV02-E01
Overview:
The purpose of this study is to conduct a multi-country, multi-site, epidemiologic study designed to assess the proportion of interferon gamma release assay (IGRA) positivity, at site level, and to build capacity to conduct a future TB vaccine efficacy study.
Find out more information on clinicaltrials.gov: https://clinicaltrials.gov/study/NCT05190146
Total Participants enrolled by Trident Clinical: 140
Enter your details and our friendly staff will be in touch with you.
Our facilities are conveniently located in a central location. On the corner of Angel and Halkett Street. A medical practice and clinical research site combined.
+27 53 050 1257
8:00am - 4:00pm
